Tech Company Financing Transactions
Crio Funding Round
Crio, operating out of Boston, scored investment capital from The Riverside Company.
Transaction Overview
Company Name
Announced On
5/23/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the expansion of its product roadmap to further enhance its value proposition to clinical research sites, biopharmaceutical companies and CROs.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
177 Huntington Ave. PMB 32876 1703
Boston, MA 02115
USA
Boston, MA 02115
USA
Phone
Website
Email Address
Overview
Our mission is to streamline clinical research to bring new medications to market faster. We are creating a holistic paperless platform for conducting clinical trials that will reduce data errors, streamline regulatory workflows and accelerate timelines.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Raymond Nomizu
VP - Customer Service
Kristen Bosse
VP - Engineering
Daniel Oberlin
Browse more venture capital transactions:
Prev: 5/23/2024: Averlon venture capital transaction
Next: 5/23/2024: Radar Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs